Ensysce Biosciences (ENSCW) Interest & Investment Income (2018 - 2021)
Ensysce Biosciences (ENSCW) reported Interest & Investment Income of $229.0 for Q1 2021, down 99.96% year-over-year from $639954.0 in Q1 2020, and down 99.96% quarter-over-quarter from $639954.0 in Q1 2020.
Ensysce Biosciences (ENSCW) Interest & Investment Income (2018 - 2021) Analysis & Trends
Ensysce Biosciences (ENSCW) has 4 years of Interest & Investment Income data on file, last reported at $229.0 in Q1 2021.
- Interest & Investment Income for Q1 2021 came in at $229.0, down 99.96% year-over-year; the trailing twelve-month figure through Mar 2021 was $2.5 million (down 32.6% YoY), and the FY2020 annual result was $719646.0, down 83.07% from the prior year.
- Interest & Investment Income retreated to $229.0 in Q1 2021 per ENSCW's latest filing, from $639954.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.2 million in Q2 2019 and troughed at $229.0 in Q1 2021.
- A 4-year average of $851680.3 and a median of $912229.0 in 2018 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2019 and 2021: Interest & Investment Income surged 70.72% in 2019, then slumped 99.96% in 2021.
- A 4-year view of Interest & Investment Income shows it stood at $1.1 million in 2018, then plunged by 32.29% to $752347.0 in 2019, then slipped by 14.94% to $639954.0 in 2020, then tumbled by 99.96% to $229.0 in 2021.
- Business Quant data shows ENSCW's Interest & Investment Income at $229.0 in Q1 2021, $639954.0 in Q1 2020, and $752347.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 229.00 |
| Mar 31, 2020 | 639,954.00 |
| Dec 31, 2019 | 752,347.00 |
| Sep 30, 2019 | 1.11 Mn |
| Jun 30, 2019 | 1.21 Mn |
| Mar 31, 2019 | 1.18 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | 969,387.00 |
| Jun 30, 2018 | 855,071.00 |
| Mar 31, 2018 | 691,167.00 |